Report Detail

Request for Sample of this report

Vascular and Non-Vascular Stents Global Market – Forecast To 2021

RnM2895566
12 March, 2020
Global
349 Pages
IQ4I Research & Consultancy
Medical Devices & Consumables

Stents are devices used in the body for treating weak or narrow blood vessels caused due to plaque formation. Stents helps in improvement of the blood flow and prevents the blood vessels from bursting. The global stents market is segmented based on the types, applications, materials, coatings, and geography. Based on the types, the stents are divided into bare metal stents, drug-eluting stents and bio-resorbable stents. By applications, the stents are divided into two segments as vascular and non-vascular stents. Vascular stents are further classified into coronary stents and peripheral stents. Peripheral stents are lower extremity & iliac stents, neurovascular stents and renal artery stents. Neurovascular stents sub segmented into carotid stents and intracranial stents. Non-vascular stents are divided into gastrointestinal, airway, urology and ophthalmology & other stents. Gastrointestinal stents are further segmented into pancreatic & biliary, esophageal, colorectal and duodenal stents. Urology stents are further segmented into ureteral & urethral stents and prostate stents. Depending on its materials, there are Metals and Polymers. Metals are segmented as cobalt-chromium, nickel-titanium, platinum-chromium, stainless steel and others whereas polymers are segmented as durable polymer and bio-absorbable polymers. Based on the coating, there are coated stents and non-coated stents. Coated stents are further segmented into inorganic, polymer, polymer-free and other coated stents. Polymer coated stents subdivided into non-biodegradable polymer and bio-degradable polymer coated stents. Geographical wise stents market segmented into North America, Europe, Asia-Pacific and Rest of the world (RoW).
Among the stents by type, drug-eluting stents occupied the largest share in 2014 and bio-resorbable stent segment is the fastest growing segment from 2014 to 2021. Based on applications, vascular stents hold the major share in 2014 and which is again the fastest growing segment at mid single digit CAGR from 2014 to 2021. Based on materials, metals occupied the largest share of 90.3% in 2014 and polymers segment is the fastest growing segment from 2014 to 2021. In case of coatings, coated stents occupied the largest share in 2014 and which is also expected to grow at high single digit CAGR offrom 2014 to 2021. Similarly by geographies, North America holds the major share of 42.3% among the geographies due to the introduction of new technologies by leading players, growing awareness and increased prevalence of arterial diseases and Asia is the fastest growing segment from 2014 to 2021 due to government initiatives for modernization of healthcare infrastructure, and increasing focus of both international and domestic players on the stents market.
The stents market is expected to grow steadily from 2014 to 2021. The factors driving the growth of this market are increasing incidence of metabolic diseases, advancement in technology, raising old age population, preference for minimally invasive solution and rise in vascular procedures. In addition to this, improving modalities of stent placements, stent adaptation in emerging regions, wide usage of stents and improvement in stent design and customized stents are some of the opportunities that are propelling the growth of the market. However, slashing prices of stents, side effects associated with stents and less adoption and long term efficacy of novel technologies are hampering the growth of the market. The threats for the stents market include reduced reimbursement, alternative procedures and stringent regulations for stent approval and medical tax.
The global stents market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares. Some of the key players of the stents market are Abbott laboratories (U.S.), B.Braun (Germany), Biosensors (Singapore), Boston scientific (U.S.), Cordis Corporation (U.S.), Medtronic (Ireland), Olympus (Japan), Microport (China), Terumo (Japan), Biotronik (Germany) Cook Medical (U.S) and C.R.Bard (U.S.).

1 EXECUTIVE SUMMARY 22

2 INTRODUCTION 29

2.1 KEY TAKE AWAYS 29
2.2 REPORT DESCRIPTION 29
2.3 MARKETS COVERED 31
2.4 STAKEHOLDERS 33
2.5 RESEARCH METHODOLOGY 33
- 2.5.1 MARKET SIZE ESTIMATION 35
- 2.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION 37
- 2.5.3 SECONDARY SOURCES 38
- 2.5.4 PRIMARY SOURCES 39
- 2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES 39
- 2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 40
- 2.5.7 ASSUMPTIONS 40

3 MARKET ANALYSIS 42

3.1 INTRODUCTION 42
3.2 MARKET SEGMENTATION 43
3.3 FACTORS INFLUENCING MARKET 46
- 3.3.1 DRIVERS AND OPPORTUNITIES 46
  - 3.3.1.1 Increasing incidence of metabolic diseases 46
  - 3.3.1.2 Advancement in technology 47
  - 3.3.1.3 Rising old age population 48
  - 3.3.1.4 Preference for minimally-invasive solutions & rise in vascular procedures....................................................................................48
  - 3.3.1.5 Improving modalities for stent placements 49
  - 3.3.1.6 Stent adoption in emerging regions 49
  - 3.3.1.7 Wide usage of stents 50
  - 3.3.1.8 Improvements in stent designing 50
- 3.3.2 RESTRAINTS AND THREATS 51
  - 3.3.2.1 Slashing stent prices 51
  - 3.3.2.2 Side effects associated with stents 51
  - 3.3.2.3 Less adoption & long term efficacy of novel technologies 52
  - 3.3.2.4 Reduced reimbursements 52
  - 3.3.2.5 Alternative procedures 52
  - 3.3.2.6 Stringent regulations 53
3.4 PORTER’S FIVE FORCE ANALYSIS 53
- 3.4.1 THREAT OF NEW ENTRANTS 53
- 3.4.2 THREAT OF SUBSTITUTES 54
- 3.4.3 BARGAINING POWER OF SUPPLIERS 55
- 3.4.4 BARGAINING POWER OF BUYERS 56
- 3.4.5 COMPETITIVE RIVALRY 56
3.5 REGULATORY AFFAIRS 56
- 3.5.1 U.S. 57
- 3.5.2 EUROPE 57
- 3.5.3 INDIA 57
- 3.5.4 CHINA 58
- 3.5.5 JAPAN 58
3.6 MARKET SHARE ANALYSIS BY MAJOR PLAYERS 60
3.7 REIMBURSEMENT SCENARIO 62
- 3.7.1 CORONARY INTERVENTIONS 62
- 3.7.2 CAROTID ARTERY STENTING 63
- 3.7.3 PERIPHERAL INTERVENTIONS 64
- 3.7.4 BILIARY STENTING 66
- 3.7.5 ESOPHAGEAL STENTING 67
- 3.7.6 COLONIC AND DUODENAL STENTING 68
- 3.7.7 TRACHEOBRONCHIAL STENTING 69
- 3.7.8 URETERAL STENTING 69
- 3.7.9 EYE STENT 70
3.8 UPCOMING TECHNOLOGIES 70
3.9 SUPPLY CHAIN ANALYSIS 83
3.10 PATENT ANALYSIS 84

4 STENTS MARKET, BY TYPES 87

4.1 INTRODUCTION 87
4.2 BARE METAL STENTS 90
4.3 DRUG ELUTING STENTS 93
4.4 BIO-RESORBABLE STENTS (BIO-ABSORBABLE STENTS & BIO-DEGRADABLE STENTS) 96
4.5 OTHERS STENTS 100

5 STENTS MARKET, BY APPLICATION 102

5.1 INTRODUCTION 102
5.2 VASCULAR STENTS 104
- 5.2.1 CORONARY STENTS 107
- 5.2.2 PERIPHERAL STENTS 110
  - 5.2.2.1 Lower extremity and iliac stents 112
  - 5.2.2.2 Neurovascular stents 114
  - 5.2.2.2.1 Carotid stents...................................................................................... 116
  - 5.2.2.2.2 Intracranial stents ............................................................................... 118
  - 5.2.2.3 Renal artery stents 120
5.3 NON-VASCULAR STENTS 121
- 5.3.1 GASTROINTESTINAL STENTS 125
  - 5.3.1.1 Pancreatic and biliary stents 127
  - 5.3.1.2 Esophageal stents 129
  - 5.3.1.3 Colorectal stents 131
  - 5.3.1.4 Duodenal stents 132
- 5.3.2 AIRWAY STENTS 134
- 5.3.3 UROLOGY STENTS 135
  - 5.3.3.1 Ureteral stents & urethral stents 137
  - 5.3.3.2 Prostate stents 140
- 5.3.4 OPHTHALMOLOGY & OTHER STENTS 141

6 STENTS MARKET, BY MATERIALS 144

6.1 INTRODUCTION 144
6.2 METAL STENTS 146
- 6.2.1 COBALT-CHROMIUM STENTS 149
- 6.2.2 NICKEL–TITANIUM STENTS 151
- 6.2.3 PLATINUM-CHROMIUM STENTS 152
- 6.2.4 STAINLESS STEEL STENTS 154
- 6.2.5 OTHERS 155
6.3 POLYMERS STENTS 156
- 6.3.1 DURABLE POLYMERS STENTS 160
- 6.3.2 BIO-ABSORBABLE POLYMER STENTS 161

7 STENTS MARKET, BY COATINGS 164

7.1 INTRODUCTION 164
7.2 NON-COATED STENTS 166
7.3 COATED STENTS 168
- 7.3.1 INORGANIC COATINGS 171
- 7.3.2 POLYMER COATED STENTS 173
  - 7.3.2.1 Non-biodegradable polymer coated stents 174
  - 7.3.2.2 Bio-degradable polymer coated stents 177
- 7.3.3 POLYMER-FREE COATED STENTS 179
- 7.3.4 OTHER COATED STENTS 181

8 REGIONAL MARKET ANALYSIS 184

8.1 INTRODUCTION 184
8.2 NORTH AMERICA 186
8.3 EUROPE 197
8.4 ASIA PACIFIC 208
8.5 REST OF THE WORLD (ROW) 220

9 COMPANY DEVELOPMENTS 233

9.1 INTRODUCTION 233
- 9.1.1 APPROVAL AS A MAJOR GROWTH STRATEGY OF ACTIVE PHARMACEUTICAL INGREDIENTS MARKET PLAYERS 234
9.2 APPROVAL 234
9.3 NEW PRODUCT LAUNCH 241
9.4 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES 245
9.5 OTHER DEVELOPMENTS 250
9.6 MERGERS & AQUSITIONS 253
9.7 BUSINESS EXPANSION 257

10 MAJOR PLAYER PROFILES 261

10.1 ABBOTT LABORATORIES 261
- 10.1.1 OVERVIEW 261
- 10.1.2 FINANCIALS 262
- 10.1.3 PRODUCT PORTFOLIO 265
- 10.1.4 KEY DEVELOPMENTS 266
- 10.1.5 BUSINESS STRATEGY 268
- 10.1.6 SWOT ANALYSIS 270
10.2 B. BRAUN MELSUNGEN AG 271
- 10.2.1 OVERVIEW 271
- 10.2.2 FINANCIALS 272
- 10.2.3 PRODUCT PORTFOLIO 274
- 10.2.4 KEY DEVELOPMENTS 275
- 10.2.5 BUSINESS STRATEGY 277
- 10.2.6 SWOT ANALYSIS 278
10.3 BIOSENSORS INTERNATIONAL GROUP 279
- 10.3.1 OVERVIEW 279
- 10.3.2 FINANCIALS 280
- 10.3.3 PRODUCT PORTFOLIO 282
- 10.3.4 KEY DEVELOPMENTS 283
- 10.3.5 BUSINESS STRATEGY 285
- 10.3.6 SWOT ANALYSIS 286
10.4 BIOTRONIK SE & CO. KG 287
- 10.4.1 OVERVIEW 287
- 10.4.2 FINANCIALS 287
- 10.4.3 PRODUCT PORTFOLIO 288
- 10.4.4 KEY DEVELOPMENTS 288
- 10.4.5 BUSINESS STRATEGY 289
- 10.4.6 SWOT ANALYSIS 290
10.5 BOSTON SCIENTIFIC CORPOARTION 291
- 10.5.1 OVERVIEW 291
- 10.5.2 FINANCIALS 292
- 10.5.3 PRODUCT PORTFOLIO 295
- 10.5.4 KEY DEVELOPMENTS 297
- 10.5.5 BUSINESS STRATEGY 298
- 10.5.6 SWOT ANALYSIS 299
10.6 C.R.BARD INC. 300
- 10.6.1 OVERVIEW 300
- 10.6.2 FINANCIALS 301
- 10.6.3 PRODUCT PORTFOLIO 302
- 10.6.4 KEY DEVELOPMENTS 304
- 10.6.5 BUSINESS STRATEGY 304
- 10.6.6 SWOT ANALYSIS 305
10.7 COOK MEDICAL INC 306
- 10.7.1 OVERVIEW 306
- 10.7.2 FINANCIALS 306
- 10.7.3 PRODUCT PORTFOLIO 306
- 10.7.4 KEY DEVELOPMENTS 307
- 10.7.5 BUSINESS STRATEGY 309
- 10.7.6 SWOT ANALYSIS 309
10.8 JOHNSON & JOHNSON (CORDIS CORPORATION) 310
- 10.8.1 OVERVIEW 310
- 10.8.2 FINANCIALS 311
- 10.8.3 PRODUCT PORTFOLIO 313
- 10.8.4 KEY DEVELOPMENTS 313
- 10.8.5 BUSINESS STRATEGY 314
- 10.8.6 SWOT ANALYSIS 315
10.9 MEDTRONIC INC 316
- 10.9.1 OVERVIEW 316
- 10.9.2 FINANCIALS 317
- 10.9.3 PRODUCT PORTFOLIO 319
- 10.9.4 KEY DEVELOPMENTS 320
- 10.9.5 BUSINESS STRATEGY 321
- 10.9.6 SWOT ANALYSIS 322
10.10 MICROPORT SCIENTIFIC CORPORATION 323
- 10.10.1 OVERVIEW 323
- 10.10.2 FINANCIALS 324
- 10.10.3 PRODUCT PORTFOLIO 326
- 10.10.4 KEY DEVELOPMENTS 327
- 10.10.5 BUSINESS STRATEGY 330
- 10.10.6 SWOT ANALYSIS 331
10.11 OLYMPUS CORPORATION 332
- 10.11.1 OVERVIEW 332
- 10.11.2 FINANCIALS 333
- 10.11.3 PRODUCT PORTFOLIO 335
- 10.11.4 KEY DEVELOPMENTS 336
- 10.11.5 BUSINESS STRATEGY 338
- 10.11.6 SWOT ANALYSIS 339
10.12 TERUMO CORPORATION 340
- 10.12.1 OVERVIEW 340
- 10.12.2 FINANCIALS 341
- 10.12.3 PRODUCT PORTFOLIO 344
- 10.12.4 KEY DEVELOPMENTS 344
- 10.12.5 BUSINESS STRATEGY 347
- 10.12.6 SWOT ANALYSIS 348

LIST OF TABLES

TABLE 1 GLOBAL STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 25

TABLE 2 GLOBAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 26

TABLE 3 GLOBAL STENTS MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 26

TABLE 4 GLOBAL STENT MARKET REVENUE, BY MATERIAL TYPE, (2013-2021) ($MN) 27

TABLE 5 GLOBAL STENT MARKET REVENUE, BY COATING TYPE, (2013-2021) ($MN) 28

TABLE 6 GLOBAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 89

TABLE 7 GLOBAL STENTS PROCEDURAL VOLUME, BY TYPE, (2013-2021) (NO’S) 90

TABLE 8 GLOBAL BARE METAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 92

TABLE 9 GLOBAL BARE METAL STENTS PROCEDURAL VOLUME, BY REGION,

(2013-2021) (NO’S) 93

TABLE 10 GLOBAL DRUG ELUTING STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 95

TABLE 11 GLOBAL DRUG ELUTING STENTS PROCEDURAL VOLUME, BY REGION, (2013-2021) (NO’S) 95

TABLE 12 GLOBAL BIO-RESORBABLE STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 99

TABLE 13 GLOBAL BIO-RESORBABLE STENTS PROCEDURAL VOLUME, BY REGION, (2013-2021) (NO’S) 100

TABLE 14 GLOBAL OTHERS STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 101

TABLE 15 GLOBAL STENTS MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 104

TABLE 16 GLOBAL VASCULAR STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 106

TABLE 17 GLOBAL VASCULAR STENTS MARKET REVENUE, BY SEGMENT,

(2013-2021) ($MN) 106

TABLE 18 GLOBAL CORONARY STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 109

TABLE 19 GLOBAL PERIPHERAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 111

TABLE 20 GLOBAL PERIPHERAL STENTS MARKET REVENUE, BY SEGMENT,

(2013-2021) ($MN) 112

TABLE 21 GLOBAL LOWER EXTREMITY & ILIAC ARTERY STENTS MARKET REVENUE,

BY REGION, (2013-2021) ($MN) 114

TABLE 22 GLOBAL NEUROVASCULAR STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 115

TABLE 23 GLOBAL NEUROVASCULAR STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 116

TABLE 24 GLOBAL CAROTID STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 117

TABLE 25 GLOBAL INTRACRANIAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 119

TABLE 26 GLOBAL RENAL ARTERY STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 121

TABLE 27 GLOBAL NON-VASCULAR STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 124

TABLE 28 GLOBAL NON-VASCULAR STENTS MARKET REVENUE, BY SEGMENT,

(2013-2021) ($MN) 124

TABLE 29 GLOBAL GASTROINTESTINAL STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 126

TABLE 30 GLOBAL GASTROINTESTINAL STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 127

TABLE 31 GLOBAL PANCREATIC & BILIARY STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 129

TABLE 32 GLOBAL ESOPHAGEAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 131

TABLE 33 GLOBAL COLORECTAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 132

TABLE 34 GLOBAL DUODENAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 133

TABLE 35 GLOBAL AIRWAY STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 135

TABLE 36 GLOBAL UROLOGY STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 136

TABLE 37 GLOBAL UROLOGY STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 137

TABLE 38 GLOBAL URETERAL & URETHRAL STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 139

TABLE 39 GLOBAL PROSTATE STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 141

TABLE 40 GLOBAL OPHTHALMOLOGY & OTHER STENTS MARKET REVENUE,

BY REGION, (2013-2021) ($MN) 143

TABLE 41 GLOBAL STENT MARKET REVENUE, BY MATERIAL TYPE, (2013-2021) ($MN) 146

TABLE 42 GLOBAL METAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 148

TABLE 43 GLOBAL METAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 149

TABLE 44 GLOBAL COBALT-CHROMIUM STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 150

TABLE 45 GLOBAL NICKEL-TITANIUM STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 152

TABLE 46 GLOBAL PLATINUM-CHROMIUM STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 153

TABLE 47 GLOBAL STAINLESS STEEL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 155

TABLE 48 GLOBAL OTHER METAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 156

TABLE 49 GLOBAL POLYMER STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 159

TABLE 50 GLOBAL POLYMER STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 159

TABLE 51 GLOBAL DURABLE POLYMER STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 161

TABLE 52 GLOBAL BIO-ABSORBABLE POLYMER STENTS MARKET REVENUE,

BY REGION, (2013-2021) ($MN) 163

TABLE 53 GLOBAL STENT MARKET REVENUE, BY COATING TYPE, (2013-2021) ($MN) 166

TABLE 54 GLOBAL NON-COATED STENT MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 168

TABLE 55 GLOBAL COATED STENT MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 170

TABLE 56 GLOBAL COATED STENT MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 170

TABLE 57 GLOBAL INORGANIC COATED STENT MARKET REVENUE, BY REGION, (2013-2021) ($MN) 172

TABLE 58 GLOBAL POLYMER COATED STENT MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 173

TABLE 59 GLOBAL POLYMER COATED MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 174

TABLE 60 GLOBAL NON-BIODEGRADABLE POLYMER COATED STENT MARKET REVENUE, BY REGION, (2013-2021) ($MN) 177

TABLE 61 GLOBAL BIO-DEGRADABLE POLYMER COATED STENT MARKET REVENUE,

BY REGION, (2013-2021) ($MN) 179

TABLE 62 GLOBAL POLYMER-FREE COATED STENT MARKET REVENUE, BY REGION, (2013-2021) ($MN) 181

TABLE 63 GLOBAL OTHER COATED STENT MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 183

TABLE 64 NORTH AMERICAN STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 188

TABLE 65 NORTH AMERICAN STENTS MARKET REVENUE, BY APPLICATION,

(2013-2021) ($MN) 188

TABLE 66 NORTH AMERICAN VASCULAR STENTS MARKET REVENUE, BY SEGMENT, (2013-2021) ($MN) 189

TABLE 67 NORTH AMERICAN PERIPHERAL STENTS MARKET REVENUE, BY SEGMENT, (2013-2021) ($MN) 190

TABLE 68 NORTH AMERICAN NEUROVASCULAR STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 190

TABLE 69 NORTH AMERICAN NON-VASCULAR STENTS MARKET REVENUE,

BY SEGMENT, (2013-2021) ($MN) 191

TABLE 70 NORTH AMERICAN GASTROINTESTINAL STENTS MARKET REVENUE,

BY TYPE, (2013-2021) ($MN) 192

TABLE 71 NORTH AMERICAN UROLOGY STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 192

TABLE 72 NORTH AMERICAN STENT MARKET REVENUE, BY MATERIAL TYPE,

(2013-2021) ($MN) 193

TABLE 73 NORTH AMERICAN METAL STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 194

TABLE 74 NORTH AMERICAN POLYMER STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 194

TABLE 75 NORTH AMERICAN STENT MARKET REVENUE, BY COATING TYPE,

(2013-2021) ($MN) 195

TABLE 76 NORTH AMERICAN STENT COATED MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 196

TABLE 77 NORTH AMERICAN POLYMER COATED MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 196

TABLE 78 EUROPEAN STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 199

TABLE 79 EUROPEAN STENTS MARKET REVENUE, BY APPLICATION,

(2013-2021) ($MN) 199

TABLE 80 EUROPEAN VASCULAR STENTS MARKET REVENUE BY SEGMENT,

(2013-2021) ($MN) 200

TABLE 81 EUROPEAN PERIPHERAL STENTS MARKET REVENUE, BY SEGMENT,

(2013-2021) ($MN) 201

TABLE 82 EUROPEAN NEUROVASCULAR STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 201

TABLE 83 EUROPEAN NON-VASCULAR STENTS MARKET REVENUE, BY SEGMENT, (2013-2021) ($MN) 202

TABLE 84 EUROPEAN GASTROINTESTINAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 203

TABLE 85 EUROPEAN UROLOGY STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 203

TABLE 86 EUROPEAN STENT MARKET REVENUE, BY MATERIAL TYPE,

(2013-2021) ($MN) 204

TABLE 87 EUROPEAN METAL STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 205

TABLE 88 EUROPEAN POLYMER STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 205

TABLE 89 EUROPEAN STENT MARKET REVENUE, BY COATING TYPE,

(2013-2021) ($MN) 206

TABLE 90 EUROPEAN STENT COATED MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 207

TABLE 91 EUROPEAN POLYMER COATED MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 207

TABLE 92 ASIA-PACIFIC STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 211

TABLE 93 ASIA-PACIFIC STENTS MARKET REVENUE, BY APPLICATION,

(2013-2021) ($MN) 211

TABLE 94 ASIA-PACIFIC VASCULAR STENTS MARKET REVENUE, BY SEGMENT,

(2013-2021) ($MN) 212

TABLE 95 ASIA-PACIFIC PERIPHERAL STENTS MARKET REVENUE, BY SEGMENT, (2013-2021) ($MN) 213

TABLE 96 ASIA-PACIFIC NEUROVASCULAR STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 213

TABLE 97 ASIA-PACIFIC NON-VASCULAR STENTS MARKET REVENUE, BY SEGMENT, (2013-2021) ($MN) 214

TABLE 98 ASIA-PACIFIC GASTROINTESTINAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 215

TABLE 99 ASIA-PACIFIC UROLOGY STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 215

TABLE 100 ASIA-PACIFIC STENT MARKET REVENUE, BY MATERIAL TYPE,

(2013-2021) ($MN) 216

TABLE 101 ASIA-PACIFIC METAL STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 217

TABLE 102 ASIA-PACIFIC POLYMER STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 217

TABLE 103 ASIA-PACIFIC STENT MARKET REVENUE, BY COATING TYPE,

(2013-2021) ($MN) 218

TABLE 104 ASIA-PACIFIC COATED STENT MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 219

TABLE 105 ASIA-PACIFIC POLYMER COATED MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 219

TABLE 106 ROW STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 223

TABLE 107 ROW STENTS MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 223

TABLE 108 ROW VASCULAR STENTS MARKET REVENUE, BY SEGMENT,

(2013-2021) ($MN) 224

TABLE 109 ROW PERIPHERAL STENTS MARKET REVENUE, BY SEGMENT,

(2013-2021) ($MN) 225

TABLE 110 ROW NEUROVASCULAR STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 225

TABLE 111 ROW NON-VASCULAR STENTS MARKET REVENUE, BY SEGMENT,

(2013-2021) ($MN) 226

TABLE 112 ROW GASTROINTESTINAL STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 227

TABLE 113 ROW UROLOGY STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 227

TABLE 114 ROW STENT MARKET REVENUE, BY MATERIAL TYPE, (2013-2021) ($MN) 228

TABLE 115 ROW METAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 229

TABLE 116 ROW POLYMER STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 229

TABLE 117 ROW STENT MARKET REVENUE, BY COATING TYPE, (2013-2021) ($MN)MN) 230

TABLE 118 ROW COATED STENT MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 231

TABLE 119 ROW POLYMER COATED MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 231

TABLE 120 APPROVAL (2013-2015) 235

TABLE 121 NEW PRODUCTS LAUNCH (2013-2015) 241

TABLE 122 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2013-2015) 246

TABLE 123 OTHER DEVELOPMENTS (2013-2015) 250

TABLE 124 MERGERS & ACQUISITION (2013-2015) 254

TABLE 125 BUSINESS EXPANSION (2013-2015) 257

TABLE 126 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES,

(2012-2014) ($MN) 262

TABLE 127 ABBOTT LABORATORIES: TOTAL REVENUE BY SEGMENTS,

(2012-2014) ($MN) 263

TABLE 128 ABBOTT LABORATORIES: TOTAL REVENUE BY GEOGRAPHY,

(2012-2014) ($MN) 264

TABLE 129 B.BRAUN MELSUNGEN AG: TOTAL REVENUE AND R&D EXPENSES,

(2012-2014) ($MN) 272

TABLE 130 B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY SEGMENTS,

(2012-2014) ($MN) 273

TABLE 131 B.BRAUN MELSUNGEN AG: TOTAL REVENUE, BY GEOGRAPHY,

(2012-2014) ($MN) 274

TABLE 132 BIOSENSORS INTERNATIONAL GROUP: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN) 280

TABLE 133 BIOSENSORS INTERNATIONAL GROUP: TOTAL REVENUE, BY SEGMENT, (2012-2014) ($MN) 281

TABLE 134 BIOSENSORS INTERNATIONAL GROUP: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 282

TABLE 135 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN) 292

TABLE 136 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENT, (2012-14) ($MN) 293

TABLE 137 BOSTON SCIENTIFIC CORPORATION: CARDIOVASCULAR BUSINESS REVENUE, BY SEGMNET, (2012-2014) ($MN) 294

TABLE 138 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 294

TABLE 139 C.R.BARD INC: TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN) 301

TABLE 140 C.R.BARD INC: TOTAL REVENUE, BY SEGMENT, (2012-14) ($MN) 302

TABLE 141 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES,

(2012-2014) ($MN) 311

TABLE 142 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENT, (2012-2014) ($MN) 312

TABLE 143 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY,

(2012-2014) ($MN) 312

TABLE 144 MEDTRONIC INC.: TOTAL REVENUE AND R&D EXPENSES,

(2012-2014) ($MN) 317

TABLE 145 MEDTRONIC INC.: TOTAL REVENUE, BY SEGMENT, (2012-2014) ($MN) 318

TABLE 146 MEDTRONIC INC.: TOTAL REVENUE, BY GEOGRAPHY, (2012-2014) ($MN) 318

TABLE 147 MICROPORT SCIENTIFIC CORPORATION : TOTAL REVENUE AND R&D EXPENSES, (2012-2014) ($MN) 324

TABLE 148 MICROPORT SCIENTIFIC CORPORATION:TOTAL REVENUE, BY SEGMENT, (2012-2014) ($MN) 325

TABLE 149 MICROPORT SCIENTIFIC CORPORATION : TOTAL REVENUE,

BY GEOGRAPHY, (2012-2014) ($MN) 326

TABLE 150 OLYMPUS CORPORATION : TOTAL REVENUE AND R&D EXPENSES,

(2012-2014) ($MN) 333

TABLE 151 OLYMPUS CORPORATION : TOTAL REVENUE, BY SEGMENT,

(2012-2014) ($MN) 334

TABLE 152 OLYMPUS CORPORATION : TOTAL REVENUE, BY REGION,

(2012-2014) ($MN) 335

TABLE 153 TERUMO CORPORATION: TOTAL REVENUE AND R&D EXPENSES,

(2011-2013) ($MN) 341

TABLE 154 TERUMO CORPORATION: TOTAL REVENUE, BY SEGMENT, (2011-13) ($MN) 342

TABLE 155 TERUMO CORPORATION: TOTAL REVENUE, BY GEOGRAPHY,

(2011-2013) ($MN) 343

LIST OF FIGURES

FIGURE 1 GLOBAL STENTS MARKET SHARE, BY GEOGRAPHY, (2013-2021) ($MN) 24

FIGURE 2 RESEARCH METHODOLOGY: STENTS MARKET 34

FIGURE 3 STENTS MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 35

FIGURE 4 STENTS MARKET: FORECASTING MODEL 36

FIGURE 5 STENTS MARKET: MARKET CRACHDOWN AND DATA TRIANGULATION 37

FIGURE 6 STENTS MARKET: MARKET SEGMENTATION 43

FIGURE 7 MARKET DYNAMICS 46

FIGURE 8 STENTS MARKET: PORTER’S ANALYSIS 55

FIGURE 9 GLOBAL STENTS MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2014 60

FIGURE 10 STENTS DEVICES MARKET: SUPPLY CHAIN ANALYSIS 84

FIGURE 11 STENTS MARKET:PATENT FILING BY MAJOR PLAYERS, (2010-2015) 85

FIGURE 12 GLOBAL STENTS MARKET REVENUE, BY TYPE, (2014 V’S 2021) ($MN) 88

FIGURE 13 GLOBAL STENTS MARKET REVENUE, BY APPLICATION,

(2013 - 2021) ($MN) 103

FIGURE 14 GLOBAL VASCULAR STENTS MARKET REVENUE, BY SEGMENT,

(2014 V’S 2021) ($MN) 105

FIGURE 15 GLOBAL NON-VASCULAR STENTS MARKET REVENUE, BY SEGMENT,

(2014 V’S 2021) ($MN) 123

FIGURE 16 GLOBAL STENTS MARKET REVENUE, BY MATERIAL, (2014 V’S 2021) ($MN) 145

FIGURE 17 GLOBAL METAL STENTS MARKET REVENUE, BY TYPE, (2014 V’S 2021) ($MN) 147

FIGURE 18 GLOBAL POLYMER STENTS MARKET REVENUE, BY TYPE,

(2014 V’S 2021) ($MN) 158

FIGURE 19 GLOBAL STENTS MARKET REVENUE, BY COATING, (2014 V’S 2021) ($MN) 165

FIGURE 20 GLOBAL COATED STENTS MARKET REVENUE, BY TYPE,

(2014 V’S 2021) ($MN) 169

FIGURE 21 GLOBAL STENTS MARKET REVENUE, BY REGION, (2013- 2021) ($MN) 185

FIGURE 22 NORTH AMERICAN STENTS MARKET OUTLOOK, BY TYPES, APPLICATIONS, MATERIALS & COATINGS, (2014 V’S 2021) ($MN) 187

FIGURE 23 EUROPEAN STENTS MARKET OUTLOOK, BY TYPES, APPLICATIONS, MATERIALS & COATINGS, (2014 V’S 2021) ($MN) 198

FIGURE 24 ASIA-PACIFIC STENTS MARKET OUTLOOK, BY TYPES, APPLICATIONS, MATERIALS & COATINGS, (2014 V’S 2021) ($MN) 210

FIGURE 25 ROW STENTS MARKET OUTLOOK, BY TYPES, APPLICATIONS, MATERIALS & COATINGS, (2014 V’S 2021) ($MN) 222

FIGURE 26 KEY GROWTH STRATEGIES (2013-2015) 233

FIGURE 27 SWOT ANALYSIS: ABBOTT LABORATORIES 270

FIGURE 28 SWOT ANALYSIS: B.BRAUN MELSUNGEN AG 278

FIGURE 29 SWOT ANALYSIS: BIOSENSORS INTERNATIONAL GROUP 286

FIGURE 30 SWOT ANALYSIS: BIOTRONIK SE & CO. KG 290

FIGURE 31 SWOT ANALYSIS: BOSTON SCIENTIFIC CORPORATION 299

FIGURE 32 SWOT ANALYSIS: C.R.BARD INC. 305

FIGURE 33 SWOT ANALYSIS: COOK MEDICAL INC. 309

FIGURE 34 SWOT ANALYSIS: JOHNSON & JOHNSON 315

FIGURE 35 SWOT ANALYSIS: MEDTRONIC INC 322

FIGURE 36 SWOT ANALYSIS: MICROPORT SCIENTIFIC CORPORATION 331

FIGURE 37 SWOT ANALYSIS: OLYMPUS CORPORATION 339

FIGURE 38 SWOT ANALYSIS: TERUMO CORPORATION 348

Dental Implant and Prosthetics Market Report

Orthopedic Devices Market Report

Summary:
Get latest Market Research Reports on Vascular and Non-Vascular Stents . Industry analysis & Market Report on Vascular and Non-Vascular Stents is a syndicated market report, published as Vascular and Non-Vascular Stents Global Market – Forecast To 2021. It is complete Research Study and Industry Analysis of Vascular and Non-Vascular Stents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on 12 March, 2020

REPORT YOU MIGHT BE INTERESTED

1-User License	$4,500.00
Site License	$6,300.00
Enterprise License	$9,000.00

1-User License	3,537.00
Site License	4,951.80
Enterprise License	7,074.00

1-User License	4,252.50
Site License	5,953.50
Enterprise License	8,505.00

1-User License	698,400.00
Site License	977,760.00
Enterprise License	1,396,800.00

1-User License	379,980.00
Site License	531,972.00
Enterprise License	759,960.00

Report Detail

Request for Sample of this report

Request for Sample of this report

Vascular and Non-Vascular Stents Global Market – Forecast To 2021

Table Of Content

1 EXECUTIVE SUMMARY 22

2 INTRODUCTION 29

3 MARKET ANALYSIS 42

4 STENTS MARKET, BY TYPES 87

5 STENTS MARKET, BY APPLICATION 102

6 STENTS MARKET, BY MATERIALS 144

7 STENTS MARKET, BY COATINGS 164

8 REGIONAL MARKET ANALYSIS 184

9 COMPANY DEVELOPMENTS 233

10 MAJOR PLAYER PROFILES 261

LIST OF TABLES

TABLE 1 GLOBAL STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 25

TABLE 2 GLOBAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 26

TABLE 3 GLOBAL STENTS MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 26

TABLE 4 GLOBAL STENT MARKET REVENUE, BY MATERIAL TYPE, (2013-2021) ($MN) 27

TABLE 5 GLOBAL STENT MARKET REVENUE, BY COATING TYPE, (2013-2021) ($MN) 28

TABLE 6 GLOBAL STENTS MARKET REVENUE, BY TYPE, (2013-2021) ($MN) 89

TABLE 7 GLOBAL STENTS PROCEDURAL VOLUME, BY TYPE, (2013-2021) (NO’S) 90

TABLE 8 GLOBAL BARE METAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 92

TABLE 9 GLOBAL BARE METAL STENTS PROCEDURAL VOLUME, BY REGION,

(2013-2021) (NO’S) 93

TABLE 10 GLOBAL DRUG ELUTING STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 95

TABLE 11 GLOBAL DRUG ELUTING STENTS PROCEDURAL VOLUME, BY REGION, (2013-2021) (NO’S) 95

TABLE 12 GLOBAL BIO-RESORBABLE STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 99

TABLE 13 GLOBAL BIO-RESORBABLE STENTS PROCEDURAL VOLUME, BY REGION, (2013-2021) (NO’S) 100

TABLE 14 GLOBAL OTHERS STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 101

TABLE 15 GLOBAL STENTS MARKET REVENUE, BY APPLICATION, (2013-2021) ($MN) 104

TABLE 16 GLOBAL VASCULAR STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 106

TABLE 17 GLOBAL VASCULAR STENTS MARKET REVENUE, BY SEGMENT,

(2013-2021) ($MN) 106

TABLE 18 GLOBAL CORONARY STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 109

TABLE 19 GLOBAL PERIPHERAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 111

TABLE 20 GLOBAL PERIPHERAL STENTS MARKET REVENUE, BY SEGMENT,

(2013-2021) ($MN) 112

TABLE 21 GLOBAL LOWER EXTREMITY & ILIAC ARTERY STENTS MARKET REVENUE,

BY REGION, (2013-2021) ($MN) 114

TABLE 22 GLOBAL NEUROVASCULAR STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 115

TABLE 23 GLOBAL NEUROVASCULAR STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 116

TABLE 24 GLOBAL CAROTID STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 117

TABLE 25 GLOBAL INTRACRANIAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 119

TABLE 26 GLOBAL RENAL ARTERY STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 121

TABLE 27 GLOBAL NON-VASCULAR STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 124

TABLE 28 GLOBAL NON-VASCULAR STENTS MARKET REVENUE, BY SEGMENT,

(2013-2021) ($MN) 124

TABLE 29 GLOBAL GASTROINTESTINAL STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 126

TABLE 30 GLOBAL GASTROINTESTINAL STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 127

TABLE 31 GLOBAL PANCREATIC & BILIARY STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 129

TABLE 32 GLOBAL ESOPHAGEAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 131

TABLE 33 GLOBAL COLORECTAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 132

TABLE 34 GLOBAL DUODENAL STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 133

TABLE 35 GLOBAL AIRWAY STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 135

TABLE 36 GLOBAL UROLOGY STENTS MARKET REVENUE, BY REGION,

(2013-2021) ($MN) 136

TABLE 37 GLOBAL UROLOGY STENTS MARKET REVENUE, BY TYPE,

(2013-2021) ($MN) 137

TABLE 38 GLOBAL URETERAL & URETHRAL STENTS MARKET REVENUE, BY REGION, (2013-2021) ($MN) 139

TABLE 39 GLOBAL PROSTATE STENTS MARKET REVENUE, BY REGION,